The longtime director of the National Human Genome Research Institute is stepping down, as the larger NIH braces for more changes.
The inquiry is the latest effort by the European Commission and European countries to scrutinize potential antitrust behavior ...
A Texas midwife has been arrested and accused of providing illegal abortions, Texas Attorney General Ken Paxton announced ...
The Trump administration earlier this year ordered all government employees to return to work in person. FDA employees whose ...
Basically, a brand-name drug company settles a patent infringement lawsuit by paying cash or transferring something else of ...
NEW YORK — Uma Reddy was sitting at her kitchen table Monday night, wrapping up patient notes, when the notice finally came: The $16.6 million grant she had used to build a maternal health ...
The Trump administration has canceled funding for an ongoing 30-year, nationwide study tracking patients with prediabetes and ...
Breaking: The WHO issued its starkest warning yet on the consequences of the abrupt cessation of U.S. global health funding, ...
How a case involving Dana-Farber Cancer Institute illustrates the potential risks for institutions when star doctors give ...
In today's Pharmalittle roundup, we're reading about Medicare negotiations, U.K. drug rebates rising, and more.
As the NIH braces for cuts of up to 5,000 of its 20,000 positions, “people are scrambling and freaking out,” a researcher said.
From STAT’s Andrew Joseph: AstraZeneca said this morning it was buying the Belgian cell therapy company EsoBiotec for $425 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback